FGL2 and neoplasm: Recent studies have reported that Fgl2 is overexpressed in hepatocellular carcinoma and that knocking down Fgl2 leads to inhibition of proliferation, which suggests that Fgl2 expression on cancer cells might be involved in tumour growth or other malignant biological behaviours13.